Archa Raises A$11M and Adds A$50M Debt for Business Credit
Australian corporate-card fintech Archa raised A$11 million of equity and secured a separate A$50 million debt facility. Here is why the financing split matters.
Australian corporate-card fintech Archa raised A$11 million of equity and secured a separate A$50 million debt facility. Here is why the financing split matters.
Allara raised $30M in stage-undisclosed venture financing, taking total funding to $75M. Its investment case rests on insurance distribution, longitudinal care and clinician-supporting AI.
Brellium raised $23M in stage-undisclosed venture financing for CortexLM, which audits clinical notes before billing. Its financial guarantee makes model accuracy an economic liability.
Albert Invent's confirmed $55M Series B backs chemistry-native AI for industrial R&D. Forbes reported a roughly $340M valuation; the company did not disclose it.
Suki's $90M Series E funds a push from ambient documentation into clinical reasoning, revenue cycle and operations. The key test is whether its dual distribution model becomes healthcare AI infrastructure.
Character.AI entered Chapter 11 in October 2026. Analyze Disney's $20M IP-license bid, the $1B unicorn history, user shutdown risks, and what investors should watch.